sulpiride has been researched along with Autoimmune Diabetes in 4 studies
Sulpiride: A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)
sulpiride : A member of the class of benzamides obtained from formal condensation between the carboxy group of 2-methoxy-5-sulfamoylbenzoic acid and the primary amino group of (1-ethylpyrrolidin-2-yl)methylamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our study first demonstrates that levosulpiride has an accelerating effect on the emptying of solids from the stomach of patients with diabetic gastroparesis." | 9.08 | Gastrokinetic effects of levosulpiride in dyspeptic patients with diabetic gastroparesis. ( De Martini, D; Mansi, C; Mela, GS; Melga, P; Perilli, D; Savarino, V; Sciabà, L; Vigneri, S, 1995) |
| "Our results show the importance of gastric emptying in the maintenance of glycemic control and the usefulness of chronic administration of levosulpiride in diabetic subjects with gastroparesis." | 9.08 | Chronic administration of levosulpiride and glycemic control in IDDM patients with gastroparesis. ( Ciuchi, E; Giusti, R; Mansi, C; Melga, P; Prando, R; Sciaba, L, 1997) |
| "Our study first demonstrates that levosulpiride has an accelerating effect on the emptying of solids from the stomach of patients with diabetic gastroparesis." | 5.08 | Gastrokinetic effects of levosulpiride in dyspeptic patients with diabetic gastroparesis. ( De Martini, D; Mansi, C; Mela, GS; Melga, P; Perilli, D; Savarino, V; Sciabà, L; Vigneri, S, 1995) |
| "Our results show the importance of gastric emptying in the maintenance of glycemic control and the usefulness of chronic administration of levosulpiride in diabetic subjects with gastroparesis." | 5.08 | Chronic administration of levosulpiride and glycemic control in IDDM patients with gastroparesis. ( Ciuchi, E; Giusti, R; Mansi, C; Melga, P; Prando, R; Sciaba, L, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, H | 1 |
| Mikami, R | 1 |
| Yonemochi, N | 1 |
| Waddington, JL | 1 |
| Melga, P | 3 |
| Mansi, C | 3 |
| Savarino, V | 1 |
| Vigneri, S | 1 |
| Perilli, D | 1 |
| Sciabà, L | 2 |
| De Martini, D | 1 |
| Mela, GS | 1 |
| Ciuchi, E | 1 |
| Giusti, R | 1 |
| Prando, R | 1 |
3 trials available for sulpiride and Autoimmune Diabetes
| Article | Year |
|---|---|
Type 1 (insulin-dependent) diabetes mellitus and gastric emptying: role of blood glucose concentration and dopamine D2 receptors.
Topics: Adult; Blood Glucose; Breath Tests; Cisapride; Cross-Over Studies; Diabetes Mellitus, Type 1; Female | 2004 |
Gastrokinetic effects of levosulpiride in dyspeptic patients with diabetic gastroparesis.
Topics: Cross-Over Studies; Diabetes Mellitus, Type 1; Dopamine Antagonists; Double-Blind Method; Dyspepsia; | 1995 |
Chronic administration of levosulpiride and glycemic control in IDDM patients with gastroparesis.
Topics: Administration, Oral; Adult; Autonomic Nervous System Diseases; Blood Glucose; Diabetes Mellitus, Ty | 1997 |
1 other study available for sulpiride and Autoimmune Diabetes
| Article | Year |
|---|---|
Regulation of plasma glucose levels by central dopamine D
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Dopamine; Dopami | 2023 |